๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Areata Alopecia

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata NCT06747611Phase 21 site๐Ÿ“ Minneapolis University of Minnesota ยท Tests: Vancomycin, Neomycin and MTT capsules, Placebo capsules PALLAS Laser for Skin Diseases NCT07250997NA1 site๐Ÿ“ Szeged Szeged University ยท Tests: UVB laser treatment Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata NCT06104839Phase 22 sites๐Ÿ“ Seoul๐Ÿ“ Seoul NEXTGEN Bioscience ยท Tests: NXC736, Placebo A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. NCT07205159Phase 16 sites๐Ÿ“ Saint Leonards๐Ÿ“ Coorparoo๐Ÿ“ South Yarra Forte Biosciences, Inc. ยท Tests: FB102, Placebo Dupilumab in the Treatment of Pediatric Alopecia Areata NCT05866562Phase 25 sites๐Ÿ“ Irvine๐Ÿ“ San Diego๐Ÿ“ Chicago Icahn School of Medicine at Mount Sinai ยท Tests: Dupilumab, Placebo A Study of LAD603 in Adults With Alopecia Areata NCT07311564Phase 21 site๐Ÿ“ Omaha Almirall, S.A. ยท Tests: LAD603, Placebo A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa NCT07136467n/a116 sites๐Ÿ“ Ciudad Autonoma de Buenos Aire๐Ÿ“ Buenos Aires๐Ÿ“ Buenos Aires AbbVie A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata NCT05723198Phase 3127 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Scottsdale Eli Lilly and Company ยท Tests: Baricitinib, Placebo Systemic Treatments for Alopecia Areata Registry NCT06283316n/a1 site๐Ÿ“ Rotterdam Erasmus Medical Center Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study NCT07381556Phase 41 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Methotrexate, Cyclosporin (CSA) A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata NCT07762443Phase 11 site๐Ÿ“ Beijing Jiangsu vcare pharmaceutical technology co., LTD ยท Tests: VC005 tablets HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata NCT07049328Phase 13 sites๐Ÿ“ Tampa๐Ÿ“ Indianapolis๐Ÿ“ Columbus HCW Biologics ยท Tests: HCW9302, an IL-2 fusion protein Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration NCT07554222Phase 11 site๐Ÿ“ Shanghai Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: placebo, Baricitinib tablets, IBI3013 Regeneron AA Multicenter (Dupilumab) NCT05551793Phase 23 sites๐Ÿ“ Irvine๐Ÿ“ New York๐Ÿ“ Rochester Emma Guttman ยท Tests: Dupilumab, Placebo A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata NCT07733765Phase 338 sites๐Ÿ“ Encinitas๐Ÿ“ Miami๐Ÿ“ Skokie Pfizer ยท Tests: Ritlecitinib 100 mg, Ritlecitinib 50 mg, Placebo Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata NCT07617597Phase 318 sites๐Ÿ“ Asahikawa๐Ÿ“ Bunkyล City๐Ÿ“ Ebina Sun Pharma Japan Limited ยท Tests: Deuruxolitinib, Placebo UV-Trichoscopic Red Fluorescence in Alopecia Areata NCT07803874n/a1 site๐Ÿ“ Istanbul Istanbul Training and Research Hospital ยท Tests: Triamcinolone Acetonide Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata NCT07133308Phase 364 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Bryant Sun Pharmaceutical Industries, Inc. ยท Tests: Deuruxolitinib, Placebo A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice. NCT07152119n/a1 site๐Ÿ“ Seoul Pfizer ยท Tests: Litfulo A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata NCT06012240Phase 3272 sites๐Ÿ“ Birmingham๐Ÿ“ Glendale๐Ÿ“ Phoenix AbbVie ยท Tests: Upadacitinib, Placebo A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) NCT07533006Phase 230 sites๐Ÿ“ Fremont๐Ÿ“ Northridge๐Ÿ“ Santa Clarita Eli Lilly and Company ยท Tests: LY4005130, Placebo Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis NCT06801821n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome NCT07242638Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Abrocitinib Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata NCT07733063n/a1 site๐Ÿ“ Istanbul Istanbul Training and Research Hospital Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata NCT06327581NA1 site๐Ÿ“ Zagazig Zagazig University ยท Tests: Lactic Acid, vit D, Triamcinolone Acetonide, Saline Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata NCT05398809Phase 21 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ ยท Tests: Ruxolitinib CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry NCT05745389n/a1 site๐Ÿ“ Waltham CorEvitas Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata NCT07749716Phase 21 site๐Ÿ“ Beijing Jiangsu vcare pharmaceutical technology co., LTD ยท Tests: Drug: VC005 tablets, VC005 tablets, VC005 placebo tablets A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata NCT06826196Phase 1, Phase 27 sites๐Ÿ“ Thousand Oaks๐Ÿ“ West Lafayette๐Ÿ“ Boston Aldena Therapeutics ยท Tests: ALD-102 Solution, Placebo or Control CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry NCT06562270n/a1 site๐Ÿ“ Waltham CorEvitas
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy